 |
| Image: .sleep-aid-tips.com |
It appears The World Health Organisation [WHO] are reviewing the GlaxoSmithKline pandemic vaccine over ties to narcolepsy. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks.
WHO were alerted to a recent study ,"Increased risk of narcolepsy observed among children and adolescents vaccinated with Pandemrix", whereby the authors found that:
Among those 4-19 years of age who received Glaxo's Pandemrix vaccine had a manifold increased risk of falling ill with narcolepsy during the 8 months following vaccination in comparison to those unvaccinated in the same age group. Based on the evaluation done so far, the National Narcolepsy Task Force finds it probable that Pandemrix®-vaccination contributed to the observed increase in incidence of narcolepsy among those 4 -19 years of age.
The study, conducted in parts of Scandanavia, found that 60 children and adolescents aged 4-19 years fell ill with narcolepsy. The figures were based on data from hospitals and primary care, and the review of individual patient records by a panel of neurologists and sleep researchers. Of those fallen ill, 52 (almost 90 percent) had received Glaxo's Pandemrix vaccine.
The report concludes:
By January 24, 2011, 56 notifications of narcolepsy in association with Pandemrix vaccination have been received by the National Vaccine Adverse Events Register maintained at the National Institute of Health and Welfare in Finland. Of these, 54 cases belonged to the age group of 4–19 years. Among most of the notified cases, the onset of symptoms of narcolepsy had started approximately two months following Pandemrix vaccination.
Not to worry though. The pharma industry can control your narcolepsy with medication such as Selective serotonin reuptake inhibitors [SSRIs]
...and so the cycle continues...
HAT-TIP - PHARMALOT
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: